Companies / Kymera Therapeutics, Inc. / Activity

Activity — Kymera Therapeutics, Inc.

62 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 4, 2026Gollob Jared
Executive
SellCommon Stock$41.3K-492
-0.40%
121,537
0.15% of shares
low
Mar 4, 2026Jacobs Bruce N.
Executive
SellCommon Stock$41.3K-492
-0.21%
236,991
0.29% of shares
low
Mar 4, 2026Gollob Jared
Executive
SellCommon Stock$38.7K-447
-0.38%
117,134
0.14% of shares
low
Mar 4, 2026Jacobs Bruce N.
Executive
SellCommon Stock$38.7K-447
-0.19%
232,588
0.28% of shares
low
Mar 2, 2026Chadwick Jeremy G
Executive
SellCommon Stock$33.9K-383
-0.48%
78,836
0.09% of shares
low
Mar 4, 2026Chadwick Jeremy G
Executive
SellCommon Stock$33.1K-394
-0.51%
77,335
0.09% of shares
low
Mar 4, 2026Chadwick Jeremy G
Executive
SellCommon Stock$31.0K-358
-0.48%
73,810
0.09% of shares
low
Apr 22, 2026Chadwick Jeremy G
Executive
SellCommon Stock$27.0K-300
-0.49%
61,202
0.07% of shares
low
Jan 20, 2026Esposito Pamela
Director
SellCommon Stock$26.7K-400
-7.27%
5,100
<0.01% of shares
low
May 26, 2026Chadwick Jeremy G
Executive
SellCommon Stock$25.7K-324
-0.56%
57,148
0.07% of shares
low
Jan 20, 2026Esposito Pamela
Director
SellCommon Stock$13.7K-200
-100.00%
0
0.00% of shares
low
Feb 25, 2026Mainolfi Nello
CEO
SellCommon Stock$748-8
-0.00%
666,195
0.80% of shares
low
← PrevPage 2 of 2Next →